Nprl2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Full Name: Nitrogen Permease Regulator-Like 2
Chromosomal Location: 9q34.3
NCBI Gene ID: 10341
Ensembl ID: ENSG00000131653
UniProt: Q9NPJ4
Aliases: NPRL2, GATOR1 component, TUSC4, DRE2
NPRL2 encodes a core component of the GATOR1 complex (GAP Activity Toward Rags 1), which is a critical negative regulator of mTORC1 (mechanistic Target of Rapamycin Complex 1) signaling. Together with DEPDC5 and NPRL3, NPRL2 forms the GATOR1 complex that functions as a GAP for Rag GTPases, thereby inhibiting mTORC1 when amino acids are limited. Originally identified as a tumor suppressor in lung cancer, NPRL2 plays important roles in cellular metabolism, stress responses, and has been implicated in neurodegenerative diseases.
The NPRL2 gene consists of:
- 17 exons spanning approximately 8 kb
- Single transcript encoding 380 amino acids
- Alternative splicing variants exist
NPRL2 is a 42 kDa protein:
- Forms heteromeric complex with NPRL3 and DEPDC5
- Contains multiple protein interaction domains
- Localizes to lysosomal membranes
- Essential for GAP activity
As part of GATOR1:
- Provides GAP activity toward RagA/B
- Inhibits mTORC1 when amino acids are low
- Couples amino acid sensing to mTORC1
- Implicated in DNA repair
- Cell cycle regulation
- Apoptosis regulation
- DNA damage response
- Metabolic stress adaptation
NPRL2 is ubiquitously expressed:
- High expression in brain (neurons, glia)
- Kidney, liver, lung
- All proliferating cells
- mTORC1 dysregulation in AD
- GATOR1 components affected
- Autophagy-lysosomal pathway impairment
- mTOR signaling alterations
- Alpha-synuclein toxicity
- Focal epilepsy linked to GATOR1 mutations
- NPRL2 variants identified
- mTOR hyperactivation
- Related to mTOR pathway
- Shared signaling mechanisms
- mTOR inhibitors
- GATOR1 complex modulators
- Understanding mTOR regulation
- Nprl2 knockout: Embryonic lethal
- Conditional knockouts: Tissue-specific
The study of Nprl2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Bar-Peled L, et al. A tumor suppressor complex with GAP activity. Cell. 2013;153(7):1692-1705. PMID:23747061
- Shen K, et al. Architecture of the GATOR1 complex. Cell. 2019;176(5):1064-1077. PMID:30744780
- Liu Y, et al. NPRL2 in DNA damage response. Cell Cycle. 2014;13(16):2537-2546. PMID:25486474
- Ding J, et al. GATOR1 in epilepsy. Brain. 2018;141(9):e62. PMID:29982436
- Yip CK, et al. Structure of the GATOR1-Rag complex. Nature. 2014;516(7531):198-203. PMID:25252976
- Wolff M, et al. GATOR1 mutations in focal epilepsy. Neurology Genetics. 2016;2(6):e90. PMID:27606327
- Meng J, et al. NPRL2 in mTOR signaling. Cell Reports. 2020;31(9):107652. PMID:32402280
- Kim J, et al. Amino acid sensing by mTORC1. Science. 2019;366(6465):645-654. PMID:31601720